Rate per 100,000 Population of Reported Cases by Age Group - 2010

Disease < 1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 0.0 0.0 0.0 0.8 1.2 7.8 11.8 12.2 8.0 2.2 6.0
Amebiasis 0.0 1.2 1.3 1.1 0.6 1.9 1.8 2.2 1.4 0.9 1.4
Anaplasmosis 0.0 0.0 1.3 0.4 1.4 0.5 2.0 1.6 2.5 4.3 2.0
Babesiosis 0.8 0.0 0.6 0.5 0.1 0.6 1.1 1.2 3.0 5.9 2.1
Botulism 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
Campylobacteriosis 27.3 24.9 15.4 10.2 13.0 17.4 12.1 14.7 16.2 14.8 15.2
Chlamydia NA NA NA 64.7 1476.5 1339.4 244.0 47.3 11.8 2.3 325.4
Cryptosporidiosis 2.3 6.0 4.1 2.0 3.6 2.9 1.9 1.6 0.9 0.6 2.0
Cyclospora 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.05 0.1
Dengue Fever 0.0 0.0 0.0 0.7 0.4 0.6 0.6 0.4 0.2 0.1 0.3
E. Coli 0157 1.6 2.1 1.2 1.0 0.7 0.8 0.4 0.1 0.3 0.8 0.7
EHEC** 2.3 4.1 1.5 1.8 1.5 1.7 0.6 0.4 0.9 1.0 1.2
Ehrlichiosis 0.0 0.4 0.1 0.0 0.1 0.1 0.3 0.3 0.2 0.8 0.3
Ehrlichiosis/Anaplasmosis Undetermined 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.1
Encephalitis (Non-West Nile) 3.1 0.0 0.3 0.1 0.2 0.3 0.4 0.1 0.3 1.1 0.4
Giardiasis 10.1 32.9 22.5 11.5 5.8 10.8 8.6 12.0 8.7 7.0 11.0
Gonorrhea NA NA NA 9.4 192.5 2.9.3 61.6 18.4 6.4 1.1 53.1
Haemophilus Influenzae 12.5 1.4 0.0 0.1 0.2 0.3 0.2 0.5 0.9 5.1 1.5
Hemolytic Uremic Syndrome 1.6 0.6 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1
Hepatitis A 0.0 0.4 0.7 0.4 0.7 0.8 0.4 0.4 0.6 0.4 0.5
Hepatitis B - Acute 0.0 0.0 0.0 0.0 0.1 0.6 0.8 1.2 0.6 0.5 0.5
Hepatitis C - Acute 0.0 0.0 0.0 0.0 0.1 1.5 1.2 0.2 0.3 0.05 0.4
HIV*** 0.8 0.0 0.0 0.4 5.3 19.3 17.0 15.9 8.0 3.1 9.0
Laboratory Confirmed Influenza 133.2 61.6 35.1 18.8 13.9 19.6 19.1 12.0 10.8 14.5 20.5
Legionellosis 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 4.1 8.3 2.7
Listeriosis 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 1.7 0.5
Lymphogranuloma Venereum NA NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.03
Malaria 0.0 0.4 0.0 0.4 0.8 1.7 1.2 0.7 0.8 0.2 0.7
Measles 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.02
Meningitis Aseptic 49.1 3.5 2.4 3.0 2.5 3.5 6.0 3.4 1.8 2.2 3.6
Melioidosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.01
Meningococcal 3.9 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1
Meningitis Other Bact. And Unknown 5.5 0.0 0.6 0.3 0.4 0.5 0.8 0.4 0.8 0.4 0.6
Mumps 6.2 13.4 22.5 20.6 12.2 7.2 3.8 1.0 0.4 0.2 5.9
Pertussis 56.1 19.8 28.7 24.0 5.9 1.4 1.9 2.6 0.9 1.1 6.5
Q Fever 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1
RMSF 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.2 0.2
Salmonellosis 60.8 29.0 16.4 11.2 12.8 14.9 10.0 10.6 8.6 11.5 13.0
Shigellosis 2.3 10.3 5.0 2.2 2.5 2.2 1.2 1.2 1.2 1.0 2.1
Strep Group A Invasive 7.0 1.6 2.8 0.4 0.7 1.1 1.9 2.3 2.5 8.0 3.1
Strep Group B Invasive 50.6 0.2 0.3 0.0 0.5 1.2 3.0 5.4 8.8 23.6 7.9
Strep Pneumonia Invasive**** 31.2 15.6 2.7 1.0 0.9 2.0 4.5 7.3 12.2 30.0 11.0
Syphilis Early NA NA NA 0.0 2.8 6.2 3.8 3.9 2.2 0.4 2.4
Syphilis Late NA NA NA 0.0 0.2 2.5 5.6 7.4 6.1 4.6 3.9
Tetanus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05 0.01
Toxic Shock Syndrome 0.0 0.2 0.1 0.1 0.2 0.0 0.2 0.2 0.2 0.3 0.2
Tuberculosis 0.8 0.8 0.6 0.3 0.9 3.4 3.4 2.7 1.9 2.5 2.2
Typhoid Fever 0.0 0.4 0.1 0.7 0.1 0.3 0.1 0.0 0.0 0.0 0.1
Vaccinia 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.04
Vibrio - Non Cholera 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.3 0.3 0.2
VISA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.6 0.2
West Nile Fever 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.4 0.3
West Nile Virus 0.0 0.0 0.1 0 0.2 0.1 0.4 0.2 0.7 1.6 0.5
Yersiniosis 0.0 0.8 0.1 0.3 0.2 0.2 0.2 0.4 0.2 0.4 0.3

Footnotes

  • * Based on report year (excludes inmates). Includes all newly-reported AIDS cases regardless of HIV diagnosis date. Provisional, data as of August 4, 2011. County of residence is unknown for 9 cases.
  • ** E.coli non-O157 and not sero-grouped shigatoxin producing infection
  • *** Based on report year (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis. Provisional, data as of August 4, 2011. County of residence is unknown for 53 cases.
  • **** Resistant, Sensitive, Intermediate, & Unknown